Author's summary Catheter ablation using the cryoballoon is a well-established treatment strategy for patients with atrial fibrillation (AF). To our knowledge, the current sub-analysis of the Cryo Global Registry is… Click to show full abstract
Author's summary Catheter ablation using the cryoballoon is a well-established treatment strategy for patients with atrial fibrillation (AF). To our knowledge, the current sub-analysis of the Cryo Global Registry is the first multicenter study describing the outcomes of cryoballoon ablation (CBA) in real-world Korea clinical practice. Overall, 299 patients were enrolled in 3 Korean centers. Safety, efficacy, healthcare utilization, and arrhythmia disease burden outcomes were assessed. This study demonstrated that CBA according to standard-of-care usage in Korea is safe and effective in preventing AF recurrence, repeat ablation, cardiovascular-related hospitalization, and AF-related symptoms at 12 months after the index ablation.
               
Click one of the above tabs to view related content.